Sandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $76.93 and last traded at $76.66, with a volume of 3549 shares trading hands. The stock had previously closed at $75.22.

Analysts Set New Price Targets

Separately, Barclays raised shares of Sandoz Group to a “strong-buy” rating in a research note on Monday, October 13th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy”.

Sandoz Group Trading Up 3.9%

The firm has a 50-day moving average of $71.48 and a two-hundred day moving average of $63.85. The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.